Phathom Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Florham Park, NJ
PHAT chart
What traders are saying about $PHAT
Latest postsPhathom Pharmaceuticals, Inc. news
- Did Phathom Pharmaceuticals’ 62% Drop Catch You Out? What Investors Missed
Simply Wall Street ·
- Phathom Pharmaceuticals, Inc. (PHAT) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- symbol__ Stock Quote Price and Forecast
CNN ·
- Phathom Pharmaceuticals provides update on FDA litigation over BDR's ANDA for generic Voquezna
Drug Store News ·
- Phathom Faces FDA Review of VOQUEZNA 2032 Exclusivity
grafa.com ·
- Form 8K Phathom Pharmaceuticals Inc For: 26 October By Investing.com
Investing.com India ·
- Phathom Pharmaceuticals: FDA Opens Comment Docket on VOQUEZNA Exclusivity Challenge
TradingView ·
- Phathom Pharmaceuticals Provides Update on FDA Litigation
Yahoo Finance ·
- Phathom Pharmaceuticals, Inc. Estimates – NASDAQ:PHAT
TradingView ·
- Phathom Pharmaceuticals (PHAT) Shares Drop 18% Amid FDA Lawsuit Over Voquezna Generic Application
GuruFocus ·
- Phathom Pharmaceuticals reports lawsuit over Voquezna exclusivity
Investing.com ·
- Form 8K Phathom Pharmaceuticals Inc For: 23 October By Investing.com
Investing.com Canada ·
Phathom Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $175.1M | $55.3M | $682,000 | $0 |
| Net income | -$221,250 | -$334,330 | -$201,590 | -$197.7M |
| Diluted EPS | $-3.03 | $-5.29 | $-3.93 | $-5.05 |
| Total assets (year end) | $259.1M | $378.3M | $413.8M | $164.8M |
| Cash and equivalents (year end) | $130.0M | $297.3M | $381.4M | $155.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Phathom Pharmaceuticals, Inc.
- Ticker
- PHAT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Florham Park, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1783183
Frequently asked questions
What exchange is Phathom Pharmaceuticals, Inc. listed on?
Phathom Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol PHAT.
What industry is Phathom Pharmaceuticals, Inc. in?
Phathom Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Phathom Pharmaceuticals, Inc. headquartered?
Phathom Pharmaceuticals, Inc.'s business address on file with the SEC is in Florham Park, NJ.
When does Phathom Pharmaceuticals, Inc.'s fiscal year end?
Phathom Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Phathom Pharmaceuticals, Inc. report?
Phathom Pharmaceuticals, Inc. reported $175.1M in revenue for calendar year 2025, according to its SEC filings.